CEFOTETAN Side Effects

6836936-1 | Haemolytic Anaemia, Hepatic Failure
on Jun 22, 2010 Female patient from UNITED STATES , 43 years of age, weighting 200.0 lb, was treated with Cefotetan (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, hepatic failure. Cefotetan dosage: Total Of 3 Doses. During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6652822-4 | Haemolytic Anaemia
Patient was taking Cefotetan (View Usage). Patient had the following side effects: haemolytic anaemia on Mar 25, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 133.0 lb, was diagnosed with appendicectomy and. Cefotetan dosage: One Time. During the same period patient was treated with STEROIDS (View Steroids Review and Steroids Label ).

6189835-5 | Asthenia, Diarrhoea, Haemolytic Anaemia, Malaise, Rash
Adverse event was reported on May 12, 2009 by a Female patient taking Cefotetan (View Usage) (Dosage: 2 Gramm X1 Iv 1 Dose) was diagnosed with perirectal abscess and. Location: UNITED STATES , 65 years of age, weighting 257.9 lb, After Cefotetan was administered, patient had the following side effects: asthenia, diarrhoea, haemolytic anaemia, malaise, rash (What is rash?). Patient was hospitalized.

6138293-5 | Acute Respiratory Failure, Disseminated Intravascular Coagulation, Haemolytic Anaemia, Post Procedural Complication, Sepsis, Syncope, Transfusion Reaction
on Mar 16, 2009 Female patient from UNITED STATES , 34 years of age, weighting 140.0 lb, was diagnosed with endometritis, prophylaxis and was treated with Cefotetan (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, disseminated intravascular coagulation, haemolytic anaemia, post procedural complication, sepsis (What is sepsis?), syncope, transfusion reaction. Cefotetan dosage: 2 Gm, Preop, Intravenous; 1 Gm, Postop, Intravenous; 2 Gm, Once, Intravenous. Patient was hospitalized.


5951132-8 | Asthenia, Dizziness Postural, Jaundice, Nausea, Syncope, Yellow Skin
on Nov 12, 2008 Female patient from UNITED STATES , weighting 96.34 lb, was diagnosed with bile duct cancer and was treated with Cefotetan (View Usage). Patient had the following side effects: asthenia, dizziness postural, jaundice (What is jaundice?), nausea (What is nausea?), syncope, yellow skin. Cefotetan dosage: . Patient was hospitalized.

5829694-0 | Abdominal Adhesions, Anaemia, Antibody Test Positive, Chest Pain, Colon Adenoma, Coombs Test Positive, Pyrexia, Reticulocyte Count Increased
Patient was taking Cefotetan (View Usage). After Cefotetan was administered, patient had the following side effects: abdominal adhesions, anaemia, antibody test positive, chest pain (What is chest pain?), colon adenoma, coombs test positive, pyrexia, reticulocyte count increased on Jul 31, 2008 from UNITED STATES Additional patient health information: Female patient , 38 years of age, weighting 197.0 lb, was diagnosed with preoperative care and. Cefotetan dosage: 2gm 1 Dose Ivpb. Patient was hospitalized.

5699409-8 | Anaphylactic Shock, Cardio-respiratory Arrest, Hypotension, Infusion Related Reaction, Tachycardia
Adverse event was reported on Mar 25, 2008 by a Female patient taking Cefotetan (View Usage) (Dosage: 2 Gm, Once, Intravenous) was diagnosed with caesarean section, prophylaxis and. Location: UNITED STATES , 33 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardio-respiratory arrest, hypotension, infusion related reaction, tachycardia. During the same period patient was treated with SPINAL EPIDURAL (View Spinal Epidural Review and Spinal Epidural Label ), PITOCIN (View Pitocin Review and Pitocin Label ). Patient was hospitalized.

5653872-7 | Carboxyhaemoglobin Increased, Haemolytic Anaemia, Hepatic Failure, Renal Failure
on Feb 29, 2008 Male patient from UNITED STATES , 61 years of age, was diagnosed with infected skin ulcer, pyrexia and was treated with Cefotetan (View Usage). Patient had the following side effects: carboxyhaemoglobin increased, haemolytic anaemia, hepatic failure, renal failure. Cefotetan dosage: . During the same period patient was treated with CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ).

5420993-3 | Haemolytic Anaemia
on Jul 03, 2006 Female patient from UNITED STATES , 48 years of age, was treated with Cefotetan (View Usage). After Cefotetan was administered, patient had the following side effects: haemolytic anaemia. Cefotetan dosage: 2g Preoperatively, 8g Postoperatively. Patient was hospitalized.

5284510-3 | Haemolytic Anaemia
Patient was taking Cefotetan (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia on Apr 03, 2006 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with antibiotic prophylaxis and. Cefotetan dosage: . Patient was hospitalized.

5284508-5 | Haemolytic Anaemia
Adverse event was reported on Apr 03, 2006 by a Female patient taking Cefotetan (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 32 years of age, Patient had the following side effects: haemolytic anaemia. Patient was hospitalized.

5284501-2 | Haemolytic Anaemia
on Apr 03, 2006 Female patient from UNITED STATES , 20 years of age, was diagnosed with prophylaxis and was treated with Cefotetan (View Usage). After Cefotetan was administered, patient had the following side effects: haemolytic anaemia. Cefotetan dosage: Given Perioperatively.. Patient was hospitalized.

5034953-8 | Haemorrhage, International Normalised Ratio Increased
on Jun 23, 2006 Male patient from UNITED STATES , 83 years of age, weighting 259.9 lb, was diagnosed with prostate cancer (What is prostate cancer?), surgery (What is surgery?) and was treated with Cefotetan (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, international normalised ratio increased. Cefotetan dosage: 1 Gm Q 12 H Iv Bolus. Patient was hospitalized.

5005194-5 | Blood Immunoglobulin G Increased, Haemolysis, Hyperbilirubinaemia, Jaundice
Patient was taking Cefotetan (View Usage). Patient had the following side effects: blood immunoglobulin g increased, haemolysis, hyperbilirubinaemia, jaundice (What is jaundice?) on May 12, 2006 from AUSTRALIA Additional patient health information: Female patient , 32 years of age, was diagnosed with caesarean section and. Cefotetan dosage: . Patient was hospitalized.

4935017-1 | Dysphagia, Dyspnoea, Erythema, Oropharyngeal Swelling, Pharyngeal Oedema, Pruritus
Adverse event was reported on Mar 06, 2006 by a Male patient taking Cefotetan (View Usage) (Dosage: 1 Gram Iv) . Location: UNITED STATES , weighting 197.0 lb, After Cefotetan was administered, patient had the following side effects: dysphagia, dyspnoea, erythema, oropharyngeal swelling, pharyngeal oedema, pruritus. Patient was hospitalized.